FDAnews Device Daily Bulletin
Medical Devices / Commercial Operations

TELA Bio Launches OviTex Portfolio

July 15, 2016
A A

TELA Bio has launched its OviTex portfolio, a suite of products intended for ventral hernia repair and abdominal wall reconstruction.

The portfolio consists of six products with a range of sizes, thicknesses and degrees of reinforcement. — Anisa Jibrell

View today's stories